{
  "id": "mhgap#risk_safety_e1ac4c67",
  "content": "AV block.\nDO NOT stop abruptly, as withdrawal can cause\nrebound hypertension. Avoid in women who are\npregnant or breastfeeding.\nLofexidine Start 0.4 - 0.6 mg twice daily. Increase Sedation, light-headedness, low blood Use caution in cardiac, cerebrovascular, and renal\nas needed by 0.4-0.8 mg daily. Maximum single pressure, ECG changes such as prolonged disease. Avoid in patients with prolonged QT\ndose: 0.8 mg. Maximum daily dose: 2.4 mg QT interval and sinus bradycardia. syndrome, metabolic disarray, or if they are taking\n(in 2-4 divided doses). any other QT-prolonging medications.\nMonitor vital signs closely.\nDO NOT stop medication abruptly, as withdrawal\nmay cause rebound hypertension.\nMEDICATIONS TO Acamprosate Start 2 tablets of 333 mg p.o. each 3 times per day Diarrhoea, flatulence, nausea/vomiting, abdominal In moderate kidney disease, give a lower dose,\nPREVENT RELAPSE for 12 months. If the person weighs less than 60 kg, pain, depression, anxiety, suicidality, itching. 333 mg p.o. 3 times per day.\nIN ALCOHOL give 2 tablets 2 times per day p.o. for 12 months. Occasionally, a maculopapular rash can occur, and\nDEPENDENCE rarely, bullous skin reactions. CONTRAINDICATED in severe kidney disease\nand liver disease.",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "high",
    "topics": [
      "stress",
      "risk_safety",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Risk Safety AV block.\nDO NOT stop abruptly, as withdrawal can cause\nrebound hypertension. Avoid in women who are\npregnant or breastfeeding.\nLofexidine Start 0.4 - 0.6 mg twice daily. Increase Sedation, light-headedness, low blood Use caution in cardiac, cerebrovascular, and renal\nas needed by 0.4-0.8 mg daily. Maximum single pressure, ECG changes such as prolonged disease. Avoid in patients with prolonged QT\ndose: 0.8 mg. Maximum daily dose: 2.4 mg QT interval and sinus bradycardia. syndrome, metabolic disarray, or if they are taking\n(in 2-4 divided doses). any other QT-prolonging medications.\nMonitor vital signs closely.\nDO NOT stop medication abruptly, as withdrawal\nmay cause rebound hypertension.\nMEDICATIONS TO Acamprosate Start 2 tablets of 333 mg p.o. each 3 times per day Diarrhoea, flatulence, nausea/vomiting, abdominal In moderate kidney disease, give a lower dose,\nPREVENT RELAPSE for 12 months. If the person weighs less than 60 kg, pain, depression, anxiety, suicidality, itching. 333 mg p.o. 3 times per day.\nIN ALCOHOL give 2 tablets 2 times per day p.o. for 12 months. Occasionally, a maculopapular rash can occur, and\nDEPENDENCE rarely, bullous skin reactions. CONTRAINDICATED in severe kidney disease\nand liver disease. Av block. do not stop abruptly, as withdrawal can cause\nrebound hypertension."
}